Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

3 Months Ended

Mar. 31, 2014

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	March 31, 2014		December 31, 2013		March 31, 2013
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	142,500	$	99,000	$	72,500
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	36,000		109,000		78,968

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	March 31, 2014		December 31, 2013		March 31, 2013
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	2,391	$	1,936	$	4,553
Currency forward contracts	Other non-current assets	128		24		—
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	1,017		872		119
Currency forward contracts	Other long-term liabilities	33		95		—
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	312		2,956		512
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	—		280		684

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended March 31,
	Statement of Operations Classification	2014			2013
Currency Forward Contracts:
Derivative instruments designated as cash flow hedges:
Gain recognized in other comprehensive income or loss	—	$	704		$	2,153
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	809			860
Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	(22		)	(43		)
Derivative instruments not designated as cash flow hedges:
Gain (loss) recognized in income	Other non-operating expense	(1,465		)	3,349